biotech news today obesity drugs glp-1 New research is challenging long-held assumptions about in weight loss treatments. A different approach may be emerging.⁠ ⁠ Click the link in bio to read the full story Eli Lilly's Obesity Pill Appears

GLP-1 is a protein hormone which helps to regulate appetite

Propensity-score matching (PSM) at a 1:3 ratio between GLP1RA and DPP4i groups was done to minimise possible selection bias

Hyperglycemia is responsible for the generation of advanced glycation end products (AGEs) that can damage the kidney through receptor (RAGE)-dependent and -independent mechanisms [55]

According to the Prescribing Information, post-marketing experience includes adverse events, such as gastrointestinal disorders and hypersensitivity

Factors Influencing Your Mounjaro Weight Loss Journey While clinical trial averages provide a strong benchmark, your individual weight loss on Mounjaro can be influenced by several factors: Starting Weight: Individuals with higher starting weights may experience a larger numerical weight loss, though the percentage of body weight lost can still be significant across various starting points

Centrally-acting appetite suppressants These act on the brains appetite and reward systems to reduce hunger and cravings